Health Management and Policy

Photo of Melissa Creary

Gene-editing treatments for sickle cell disease may be out of reach for many

Q&A with Melissa Creary

Federal approval of a breakthrough gene-editing technology that treats the pain and debilitating effects of sickle cell disease is cause for celebration among a community with few options for relief, but it also comes with concerns that too few people can afford to pay for the therapy.